India’s pharmaceutical industry, valued at around US$58 billion, is projected to reach US$120-130 billion by 2030 and US$400-450 billion by 2047. Growth is driven by rising lifestyle diseases, an aging population, increased focus on holistic health, and the growing consumerization of healthcare. India allows 100 percent FDI under automatic approval for greenfield investments and up to…
India’s pharmaceutical industry is currently valued at approximately US$58 billion, with projections indicating growth to US$120-130 billion by 2030 and US$400-450 billion by 2047. Key factors driving this expansion include the rising prevalence of lifestyle-related diseases, an aging population, increased focus on holistic health and well-being, and the growing consumerization of healthcare.
India hosts the…
The pharmaceutical sector is showcasing growth daily, developing, introducing, and marketing pharmaceuticals products. Pharmaceutical products are the result of a variety of laws and regulations universally. The increasing demand for products and compliance with strict regulations made the pharmaceutical companies outsourcestrong Pharmaceutical Contract manufacturers.
As this industry follows multifaceted compliance as required by law and procedure,…
Often hailed as the 'pharmacy of the world,' the Indian pharmaceutical industry is booming. It jumped from $40 billion in 2021 to an expected $130 billion in 2030, with projection hitting Beyond just keeping up with the demand at home, the Indian pharma industry commands over 20% of the global pharma supply chain and addresses…
India is the world’s leading manufacturer of pharmaceutical products, with the industry ranking third in terms of volume. Because of its enormous contribution to the world, the industry is gaining more and more success these days.
Manufacturing functionalized APIs
Active Pharma Ingredients (APIs) are the raw materials that go into manufacturing medicines. APIs are those ingredients that facilitate the intended health effects of the medicine. Many leading companies that manufacture specialized APIs are renounced for their immense contribution to alleviating the Indian healthcare system. Thus, The Indian pharmaceutical industry has earned its…
What will it take for India to become a global pharma powerhouse by 2047?
Discover the insights from top industry leaders and explore how India is setting the stage to become the world’s pharma powerhouse.
In brief
India’s pharma sector is set to reach US$450 billion by 2047, with a focus on self-reliance, innovation and global expansion.
Next wave of industry growth will be driven by innovation in next-generation…
To maintain profitable and resilient operations, CEOs and COOs of pharma companies may need to make bold changes to their operations strategy as the industry navigates new challenges.
many pharmaceutical companies (pharmacos) deprioritized operations strategy in the face of competing business pressures. This is now changing. Factors such as the COVID-19 pandemic, inflation, geopolitics, new therapeutic…
Pharmaceutical Sector Spotlight: Driving Innovation in India
India's pharmaceutical sector has emerged as a global leader in research and innovation, driven by a combination of a robust scientific and technological base, growing government support, a strong domestic market, and cost-competitive manufacturing.
The sector contributed nearly 1.32% of the Gross Value Added to the Indian Economy…
New York, United States, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The pharmaceutical manufacturing market refers to the global industry producing pharmaceutical drugs or medications. It encompasses various activities, including research, development, formulation, production, quality control, packaging, and distribution of pharmaceutical products. This market is driven by the increasing desire for pharmaceutical drugs to prevent, treat,…
